Despite just 45 generic drug approvals and 17 tentative approvals in June, the US Food and Drug Administration (FDA) told Focus that the dip, from an average of about 89 approvals and 23 tentative approvals in the previous eight months, is not due to a specific issue.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,